Patents by Inventor Brian Moldt

Brian Moldt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTI-SPECIFIC ANTIGEN BINDING MOLECULES TARGETING HIV AND METHODS OF USE
    Publication number: 20230056252
    Abstract: Provided are multi-specific antigen binding molecules, including bispecific antibodies, that bind to CD3 and an HIV antigen, including HIV envelope protein gp120. Also provided are methods of using such antigen binding molecules to treat or prevent HIV infection.
    Type: Application
    Filed: August 23, 2021
    Publication date: February 23, 2023
    Inventors: Manuel Baca, Wade S. Blair, Brian A. Carr, Sheila B. Clancy, Joshua Goldsmith, Magdeleine S. Hung, Manu Kanwar, Brian Moldt, Mark Nagel, Craig S. Pace, YenRu Pan, Heather T. Stephenson, Nathan D. Thomsen
  • METHODS OF IDENTIFYING HIV PATIENTS SENSITIVE TO THERAPY WITH gp120 CD4 BINDING SITE-DIRECTED ANTIBODIES
    Publication number: 20220144923
    Abstract: Provided are methods for identifying patient populations infected with HIV that can be targeted by antibodies that bind to HIV gp120 CD4 binding site (CD4bs) region.
    Type: Application
    Filed: November 9, 2021
    Publication date: May 12, 2022
    Inventors: Stephen R. Martin, Brian Moldt, Aiyappa Parvangada
  • METHODS OF IDENTIFYING HIV PATIENTS SENSITIVE TO THERAPY WITH GP120 V3 GLYCAN-DIRECTED ANTIBODIES
    Publication number: 20200368347
    Abstract: Provided are methods for identifying patient populations infected with HIV that can be targeted by antibodies that bind to HIV gp120 V3 glycan region.
    Type: Application
    Filed: May 18, 2020
    Publication date: November 26, 2020
    Inventors: Brian Moldt, Craig S. Pace
  • Pig whose genome comprises a heterologous site-specific recombination site and a transpohon tag
    Patent number: 8581021
    Abstract: The present invention relates to a genetically modified pig comprising at least one site for integration of at least one transgene. The invention also pertains to a porcine embryo, blastocyst, fetus, donor cell and/or cell nucleus, derived from said genetically modified pig. In another aspect, the invention relates to any genetically modified porcine blastocyst, wherein the genetically modified genome comprises at least one site for integration of at least one transgene.
    Type: Grant
    Filed: March 7, 2008
    Date of Patent: November 12, 2013
    Assignee: Aarhus Universitet
    Inventors: Jacob Giehm Mikkelsen, Brian Moldt, Anders Lade Nielsen, Lars Axel Bolund, Peter Michael Kragh, Jannik Ejnar Jakobsen, Arne Lund Jørgensen
  • PIG MODEL
    Publication number: 20100154069
    Abstract: The present invention relates to a genetically modified pig comprising at least one site for integration of at least one transgene. The invention also pertains to a porcine embryo, blastocyst, foetus, donor cell and/or cell nucleus, derived from said genetically modified pig. In another aspect, the invention relates to any genetically modified porcine blastocyst, wherein the genetically modified genome comprises at least one site for integration of at least one transgene.
    Type: Application
    Filed: March 7, 2008
    Publication date: June 17, 2010
    Applicant: AARHUS UNIVERSITET
    Inventors: Jacob Giehm Mikkelsen, Brian Moldt, Anders Lade Nielsen, Lars Axel Bolund, Peter Michael Kragh, Jannik Ejnar Jakobsen, Arne Lund Jørgensen